LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

• Kanso combines best-in-class hearing performance with a discreet design that puts hearing loss out of sight Cochlear Limited (ASX: COH), the world leader in implantable hearing solutions, today ...

An update from Cochlear ( (AU:COH)) is now available. Cochlear Limited has received FDA approval for its Cochlear™ Nucleus® Nexa™ System and Nucleus Kanso® 3 and Kanso® 3 Nexa Sound Processors, with ...

Cochlear Limited, the global leader in implantable hearing solutions, announced the US Food and Drug Administration (FDA) approval of the Cochlear Nucleus Nexa System – the world’s first and only, ...

Until now, recipients of cochlear implants have been limited to accessing new technology through the external part of their cochlear implant system – the sound processor – and have typically needed a ...

India, Sep 2: Cochlear Limited released its newest innovation – Kanso – a sound processor combining the most advanced sound processing technology with a discreet design. Ms Vandana Pisharody, Regional ...

Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.